Renal medullary carcinoma (RMC) is a rare entity with poor prognosis bearing inactivating genomic alterations in <i>SMARCB1/INI1</i> resulting in the loss of expression of INI1 and occurring in young patients with sickle cell trait or sickle cell disease. This evidence concerns the gene SMARCB1 and kidney medullary carcinoma.